Ilc Therapeutics
ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy. ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, Alfacyte™ and Dermacyte™ focused on antiviral and dermatological indications respectively, which are progressing towards the clinic.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
1
organic / mo
Sign up free to see all 3 verified contacts at Ilc Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- DF
Dawn Firmin
Head of Technical Operations · Other
EmailPhone - DH
David Harrison
Non Executive Director · General Business & Management
EmailPhone - AW
Alan Walker
Chief Executive Officer · General Business & Management
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Ilc Therapeutics
3 distinct titles indexed · top 3 shown.
- 1chief executive officer
- 1head of technical operations
- 1non executive director
Sign up to unlock all 3 contacts at Ilc Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Ilc Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.